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Abstract
Gingivitis and periodontitis are induced by numerous pathogenic microbiota 
hosted in the subgingival biofilm that first trigger the innate immune response. 
Innate immune response is part of a homeostatic system which is the first line 
defence and defines the host inherited resistance to infection. Both genetic and 
environmental factors are involved in variable individual susceptibility to inflam-
mation of periodontal tissues. That is why, although more than 600 bacterial 
species have been detected in the periodontal plaque, the type of bacteria incrimi-
nated in the development of the inflammation is still unclear. Moreover, in the last 
decade gene polymorphisms have been largely recognised as important conditions 
associated with increased susceptibility to periodontal diseases. Manipulating the 
immune response by the development of drugs that inhibit adverse host reactions 
and promote beneficial effects might be of therapeutic or prophylactic importance. 
This work intends to assess the importance of Toll-like receptors as main effectors 
of the innate immune response in the triggering, maintenance and progression of 
periodontal inflammation, as well as of the involvement of synthetic molecules 
targeting TLR signalling pathways in treating periodontal diseases.
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1. Introduction
The surface of the mouth is lined by the oral mucosa which was often considered 
to be more of a mechanic barrier than an active player involved in the modulation of 
the host response to various external stimuli in order to maintain mouth homeostasis.
The oral mucosa is permanently insulted by mechanic and chemical factors (like 
smoke, xenobiotics) as well as a plethora of microorganisms. Both the commensal 
and pathogen microorganisms, depending on their structure, represent triggers 
for the immune surveillance players hosted by the oral mucosa which have been 
intensively studied in the last years. Local defence in the oral cavity is provided 
by a complex network of cells with their receptors and molecules through which 
they respond to various ligands (microbial antigens, tissue degradation products, 
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nucleic acids). The interactions between gingival resident cells and oral microbiome 
are characteristic of clinical gingival health and homeostasis as well as for gingival 
inflammation. Host defence takes place in successive, sometimes overlapping 
stages. The innate immune response represents a homeostatic system which is the 
first line defence and defines the host inherited resistance to infection.
The immune system has a hierarchical organisation, all the immune and non-
immune cells involved being able to sense the pathogens through pattern recogni-
tion receptors (PRR) and then develop the immune response triggered by numerous 
proinflammatory mediators. PRRs detect and respond to conserved patterns origi-
nated in microorganisms and stress signals called pathogen- or damage-associated 
molecular patterns (PAMPS and DAMPS) [1].
Among PRRs, Toll-like receptors (TLRs) are the most intensively studied. In the oral 
mucosa TLRs are expressed in cells of the immune system including neutrophils, mono-
cytes, macrophages, and not less important, dendritic cells, keratinocytes and endo-
thelial cells. [2] TLR activation induces the local synthesis of cytokines and chemokines 
through different pathways. Part of these molecules are involved in the development of 
highly specific adaptive immunity ensured by T and B lymphocytes. Due to this ability, 
TLRs are considered to be the missing link between innate and acquired immunity.
Manipulating the oral immune response by development of drugs that inhibit 
adverse host reactions and promote beneficial effects might be of therapeutic or 
prophylactic importance in periodontal diseases.
This review intends to assess the importance of Toll-like receptors as main 
effectors of the innate immune response in the triggering, maintenance and 
progression of periodontal inflammation as well as of the involvement of synthetic 
molecules targeting TLR signalling networks in treating periodontal diseases.
2. Methodology
This chapter has been designed in order to assess the role of innate immune 
receptors, especially Toll-like receptors, as main effectors of the innate immune 
response triggered by various pathogens hosted in the subgingival film which are 
able to onset periodontal inflammation, as well as the involvement of synthetic 
molecules targeting TLR signalling pathways in treating periodontal diseases. 
Information processed has been sourced from the existing scientific literature and 
supplemented with our personal findings from experimental studies regarding TLR 
involvement in mediating innate immune response at oral mucosa level. We searched 
MEDLINE, Web of Science, SCOPUS, without language restriction, following terms 
„innate immunity” AND „periodontal inflammation” OR „periodontal disease” AND 
„TLR” OR „TLR therapeutic targets”. Identification of specific literature also included 
manual search and screening of the citations of the relevant studies. The included 
studies were selected after reviewing the abstract and full-text for eligibility.
3. Oral mucosa cells and the innate immune response
The oral mucosa consists of a stratified oral epithelium formed by keratinocytes 
lining the inner connective tissue or lamina propria which has as main cells the 
fibroblasts and also proinflammatory cells originated in the bone marrow.
Three distinct phenotypes of oral mucosa are noted: lining, masticatory and 
specialised mucosa. The lining mucosa cover almost the entire mouth, excepting 
the rigid structures, such as the alveolar processes and the hard palate, which are 
covered by the masticatory mucosa, and the dorsal part of the tongue coated by the 
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specialised mucosa. [3] The crevicular (CE) and junctional epithelium (JE) are the 
keystones for the antimicrobial barrier function of the oral mucosa. Compared to 
other types of epithelial cells, JE possesses fewer intercellular junctions, just desmo-
somes, and more intercellular spaces filled with gingival crevicular fluid (CF). Due 
to this histophysiology, JE allows the passage of CF, the carrier of inflammatory cells 
and soluble mediators, from the gingival connective tissue to the crevicular space. 
The changes of the dental biofilm and the metabolic products of bacteria trigger 
the synthesis of cytokines and increase the number of polymorphonuclear cells 
(PMNs) migrating to the initial site of inflammation. This early event, gingivitis, 
is followed by the appearance of other inflammatory cells (macrophages, lympho-
cytes, mononuclear and dendritic cells) and the persistence of inflammation of the 
teeth supporting tissues with progressive attachment loss and bone destruction, 
namely periodontitis. [4] The proinflammatory cells of the oral mucosa connective 
tissue are myeloid-originated immune cells such as monocytes, macrophages and 
dendritic cells which act as the first line of defence during infection, recognising, 
engulfing and killing bacteria, fungi or viruses. Recent data emphasises that it is not 
only the immune cells but also the fibroblasts and the keratinocytes that contribute 
to local immunity through the activation and modulation of specific immune 
receptors. [5] Fibroblasts activation triggered by the immune cells is involved in 
the remodelling of the extracellular matrix (ECM); moreover, under the stimula-
tion of the endothelial cells derived signals, fibroblasts are able to differentiate 
into myofibroblasts important for wound healing of the masticatory mucosa. [6] 
Knowledge of how immune mechanisms and responses are controlled is essential 
for understanding the pathogenesis of periodontal inflammation. Bacteria are 
the most common pathogens in the case of gingivitis, followed by periodontitis, 
but both pathologies can also be caused by other pathogens like fungi, viruses or 
by metabolic imbalances. Until recently, innate and specific/adaptive immune 
responses had been arbitrarily proposed by immunologists as two distinct stages 
of the immunologic events. Later it was clarified that adaptive or acquired immune 
response evolved around innate immunity instead of replacing it. The develop-
ment of acquired immunity is regulated through the activation of some myeloid 
and antigen presenting cells (APCs). Innate immunity should be considered as an 
immune system skill developed in order “to buy time” [7] until the acquired, more 
efficient host immune response, is primed. The immune system has a hierarchical 
organisation containing immune cells (monocytes, macrophages, neutrophils, den-
dritic cells (DCs), natural killer cells (NK), mast cells, eosinophils, basophils and 
newly identified innate lymphoid cells (ILCs), mucosal associated invariant T cells, 
ɣδT cells) and humoral circulating components (complement proteins, cytokines 
and chemokines secreted by those cells, along with various antimicrobial peptides, 
AMPs). [2, 8–11] All the cells already mentioned are able to sense the pathogens 
through PRRs and then develop the innate immune response. [12] A limited number 
of PRRs are able to recognise a large number of pathogens. PRRs detect and respond 
to conserved motifs originated in microorganisms and stress signals called PAMPS 
and DAMPS. [1] PAMPs are evolutionarily conserved structures shared among 
pathogens, but not present in eukaryotes, which confer specificity to the innate 
immune response. These include lipopolysaccharides, peptidoglycans, bacterial 
lipoproteins, DNA and double stranded RNA. [7] DAMPs are endogenous ligands 
derived from host cells (tumour cells, dying cells) or products released from cells in 
response to various signals which produce inflammation in the absence of infection. 
DAMPs are often created in environments of trauma, ischemia, or tissue damage 
involved in various diseases (cancer, autoimmune disease, and atherosclerosis) and 
do not require pathogens infection. [1, 13] Inside the more generic term microbial-
associated molecular patterns (MAMPs), one could consider commensal-associated 
Periodontology - Fundamentals and Clinical Features
4
molecular patterns (CAMPs), as many microorganisms colonise the human body 
without causing disease. [14] PAMPs, MAMPs and DAMPs bind to PPRs which 
include mainly Toll-like receptors (TLRs), transmembrane C-type lectin-like recep-
tors (CLRs), cytoplasmic NOD-like receptors (NLRs) and intracellular retinoic 
acid-inducible gene-I-like receptors (RLR). [13, 15] PRR-ligand binding and their 
concomitant conformational changes prompt a cascade of downstream signalling 
that results in transcriptional and post-translational changes. Among these PRRs, 
TLRs have been studied most extensively.
4. Toll-like receptors: structure, ligands and signalling
TLRs, so called because they are similar to the product of the Toll gene identified 
in Drosophila, are the best characterised from all the classes of PRRs. Until now, ten 
human TLRs have been described, the first being reported 26 years ago by Nomura 
in 2004 [16] and called TLR1. TLRs are evolutionary conserved transmembrane 
glycoproteins that contain an extracellular (or intra-cytosolic for those intracellular 
TLRs expressed in endosomes) N-terminal leucin-rich-repeat (LRR) domain, a 
transmembrane domain and an intra-cytoplasmic Toll/IL-1R (TIR) domain. LRR is 
responsible for ligand recognition and binding while TIR domain for intracellular 
signal transfer. [14] It is generally accepted that most TLRs are localised to the cell 
surface (TLR1, TLR2, TLR4, TLR5, TLR6 and TLR10) and recognised extracellular 
microorganisms and ligands, while TLR3, TLR7, TLR8 and TLR9 are intracellular, 
hosted into the cytosolic endosomal compartment and recognised molecular pat-
terns that have already passed the cell membrane. [14] Recently has been demon-
strated that TLR2 and TLR4are also present inside some cells: DCs, monocytes, 
epithelial and endothelial cells. [17, 18] The cells expressing TLRs in humans and 
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In physiologic conditions, the intracellular TLRs have no contact with host cells 
derived nucleic acids because they are sequestered in endosomes and no innate 
response is signalled against own nucleic acids. In some pathologic conditions, TLRs 
signal the synthesis of autoantibodies against host own nucleic acids, for example 
in rheumatoid polyarthritis, much evidence showing the link between rheumatoid 
arthritis and periodontal disease [23] which may suggest a similar expression of 
these receptors in the diseases having in common the destruction of hard tissues.
TLR 1, TLR2, TLR4, TLR5 and TLR6 recognise mainly unique bacterial products 
and not those produced by the host, which gives them the ability to differentiate 
microorganisms from the host and conveys some degree of specificity, making them 
the missing link between the innate and acquired immunity. [24].
TLR2 and TLR4 are the most defined members of this family. TLR2 forms 
heterodimers with TLR1 and TLR6 and recognises peptidoglycans, lipopeptides 
and lipoproteins, while TLR4 is the acknowledged PRR for lipopolysaccharide 
(LPS) and Gram-negative bacteria. Published data is conflicting regarding the 
ability of TLR4 to recognise Porphyromonas gingivalis and Escherichia coli LPS, some 
authors considering that TLR4 is able to detect only E. coli product. [25, 26] TLR3 
recognises double-stranded RNA (dsRNA), TLR7 and TLR8 are known to recognise 
single-stranded RNA (ssRNA). TLR5 detects bacterial flagellin and TLR9 recognises 
cytosine and guanine base-pairing of bacterial and viral DNA [3, 27, 28].
LRR domain of TLRs is involved in the recognition of various ligands. LRR ligand 
binding induces the formation of TLRs homodimers or heterodimers followed by 
a conformational change of the TIR domain which allows the interaction between 
TIRs of adjacent TLRs in order to bind an additional adapter protein essential to 
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*In human blood, two subpopulations of DCs precursors are present – myeloid or conventional and plasmacytoid -  
different in terms of cell phenotype and morphology, which express various TLRs. Plasmacytoid DCs recognise 
predominantly viral antigens through the activation of TLR7 and TLR9 [19, 20]. Myeloid or classical DCs recognise 
both bacterial and viral antigens [21, 22].
Table 1. 
Toll-like receptors expressing cells in humans and their ligands.
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In the same cell, the activation of different TLRs induces various proinflamma-
tory responses. For example, the interaction of TLR3 and TLR4 with LPS in DCs 
triggers the synthesis of IL-12, and respectively type 1 interferon [29].
The same TLR can trigger a different response depending on the upper intracel-
lular adapter protein [30].
To date, two different pathways are recognised for the intracytoplasmic signal-
ling cascade of TLRs: (i) the myeloid differentiation primary response protein 88 
(MyD 88) dependent pathway – the most important – essential for the majority 
of TLR-mediated cell activation, and (ii) MyD88-independent pathway, after 
TLR3 and TLR4 stimulation takes place. Even if the cells are forced to react to an 
extensive number of PAMPs, only four adapter molecules have been identified for 
both pathways: MyD88, toll/interleukin-1 receptor domain-containing adapter 
protein (TIRAP), toll/interleukin-1 receptor domain-containing adapter-inducing 
interferon beta (TRIF) and toll/interleukin-1 receptor domain-containing adapter-
inducing interferon beta-related adapter molecule (TRAM) [3, 7, 14, 29, 31].
MyD88-dependent signalling predominantly leads to nuclear factor-kB (NF-kB)  
activation while the TRIF-dependent pathway, MyD88-independent, leads to 
interferon-regulatory factor 3 (IRF3) and to a lesser extent to NF-kB activation. [31] 
NF-kB is a crucial transcription factor that promotes the expression of genes encod-
ing proinflammatory and chemotactic cytokines, such as IL-1, IL-12, IFNɣ, CXCL9, 
CXCL10, costimulatory molecules and other effectors. [32–34] Apart from NF-kB 
activation, TRIF-dependent pathway induces the expression of type I interferons, 
mainly IFNβ [31, 35].
5. Toll-like receptors in periodontal diseases
Both in gingivitis and periodontitis a plethora of bacterial germs are accumu-
lated in the gingival mucosa around the tooth, particularly in the gingival crevice. 
[29] More than 600 species populate the oral cavity [36, 37] with a clearest distinc-
tion between those characteristic of shedding epithelia (oral mucosa) and non-
shedding surfaces - the tooth biofilm. The complex studies of oral microbiota have 
demonstrated a conspicuous change of the oral bacterial populations before and 
during the periodontal disease, making possible the definition of the ‘red complex 
bacteria’ including Porphyromonas gingivalis, Tannerella forsythia and Treponema 
denticola. [38–40] Recent investigations partially disagree with this paradigm and 
collectively suggest that the pathogenesis of periodontitis involves not only a poly-
microbial synergy and a dysbiosis - the PSD model, but also a host susceptibility to 
chronic inflammatory disorders leading to an unbalanced immune response, which 
may trigger the limited success of the antimicrobial treatment [40].
Oral tissues homeostasis involves the balance between the oral mucosa with 
its immunocompetent cells and the extreme vast oral microbiota. In this paper we 
do not intend to characterise the oral microbiota but the innate immune response 
of the oral structures to various germ triggers of inflammatory periodontal 
inflammation.
Regarding the development of dental plaque two main events imply the impor-
tance of the innate immune response. On one hand, gingivitis does not necessarily 
lead to periodontitis, which suggests that, despite massive dental plaque accumula-
tion, stable gingival inflammation may represent a protective host response. [41] 
On the other hand, in cases in which gingivitis evolves to periodontitis, plaque 
accumulation induces the development of a dysbiotic, inflammophilic microbiota. 
Each of these events depends, in great part, on host ability to control the resolution 
of the inflammatory processes [40].
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Due to the presence of a constantly large number of microorganisms in the 
oral cavity, TLR expression is essential for the maintenance of oral tissue immune 
homeostasis. Porphyromonas gingivalis (P. gingivalis) has recently been described as a” 
corrupter” of the innate immunity manipulating the host response rather than induc-
ing by itself a chronic inflammation, being a low abundance constituent in rodent 
and also in human periodontitis associated biofilm. [42, 43] Such a germ is called 
a”keystone germ” able to impair host defence in order to compromise the homeosta-
sis between the commensal microbiota and the host immune response. Under the 
influence of a keystone germs, the commensal bacteria become pathobionts, nor-
mally harmless symbionts that can become pathogenic under certain environmental 
conditions. Actually, no bone loss is effective in periodontitis induced by P. gingivalis 
in the absence of commensal microbiota. Even incomplete, an explanation of the 
corruption effect on TLR innate immune system by the commensal germs could be 
the observation that commensals and symbionts share similar MAMPs (LPS, pepti-
doglycans, lipoproteins) with pathogens, so they could induce PRRs activation [44].
In the oral mucosa, TLRs are predominantly expressed in neutrophils, mono-
cytes, macrophages, and equally important DCs. Albeit the macrophages and DCs 
represent”professional APCs”, the first cells responding to PAMPs are the epithelial 
cells from the oral mucosa, precisely the crevicular lining cells. As APCs, DCs and 
macrophages are responsible for the presentation of the antigen fragments together 
with the MHC class II to T cells in order to induce a costimulatory response.
Because TLRs are present in cells from all the structures of the oral mucosa 
either directly related to the immune local defence or not and their activation leads 
to redundant local inflammatory reactions, we intend to use a mechanistic approach 
to their effects in periodontal disease.
5.1 TLR signalling in the oral epithelium
Although the expression of mRNAs for TLR1 to TLR9 has been detected in the 
oral epithelial cells, the immunolocalisation of the corresponding proteins was 
variable. Immunohistochemical studies revealed that TLR1 to TLR9 are differen-
tially expressed in the epithelial layers and connective tissue of the gingival samples 
collected from patients with periodontitis and healthy subjects. [45, 46] Increased 
TLRs expression towards the basal layer of the epithelium and the connective tissue 
in samples with periodontitis sustains their involvement in the pathogenesis of 
this disease. The percentage of TLR4 positive cells was higher in the spinous layer 
keratinocytes of the healthy tissues in contrast to the periodontitis samples which 
revealed higher expression in the basal keratinocytes.
TLR2 and TLR4 are the most studied receptors in relation to periodontal tis-
sues. Mori et al. studied the immunohistochemical expression of TLR2, TLR4 and 
CD14 in samples of oral mucosa classified according to the degree of inflammation. 
They found that the ratio of TLR4 positive cells was higher in samples from the 
more severe inflamed tissue and that of TLR2 positive cells was the highest in the 
connective tissue subjacent to pocket epithelium of the severe inflamed group. [47] 
Becerik and co-workers reported the same expression of TLR4 in tissue excised 
from periodontitis sites. [48] Depending on the state of inflammation, TLR2 is 
highly expressed in the cells of the gingival basal layer and lower reaction was 
observed in cells of the superficial layers more exposed to pathogens. [33, 45] They 
presume this expression as a strategy of TLR2 to recognise the pathogens only 
when they invade the superficial layers of the oral epithelium in order to limit the 
overexpression of the proinflammatory cytokines and to maintain the oral tissue 
homeostasis. In bacterial periodontitis, TLR4 expression in gingival cells decreased 
in order to minimise the damage of oral tissues and bone. [49] This observation is 
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in accordance with that reported by [50] regarding the decreased number of DCs in 
the oral epithelium of periodontitis samples compared to non-inflamed mucosa or 
gingivitis.
We performed an immunohistochemical study for TLR2 and TLR4 expression 
on samples collected from patients with various degree of gingival inflammation. 
In samples with gingivitis, we observed that TLR2 is expressed evenly in almost all 
layers of the gingival epithelium except in the superficial layer (Figure 1a,b). In the 
basal and parabasal layers, we noticed TLR2 positivity in dendritic extensions pos-
sibly belonging to Langerhans cells, in addition to an inconstantly positive reaction 
in keratinocytes (Figure 1c). Regarding TLR4 expression, we observed a decrease of 
positivity in the epithelium from the superficial layers to the basal one (Figure 1d). 
In the connective tissue, we noticed more TLR2 positive proinflammatory cells than 
TLR4 positive (unpublished data). In periodontitis samples, the immunohistochemi-
cal reaction for TLR2 in the epithelium was more intense than in gingivitis, TLR2 
Figure 1. 
TLR2 and TLR4 expression in gingivitis. (a) TLR2 positive keratinocytes into the basal and parabasal layers of 
the gingival epithelium; (b) Same positive reaction in the epithelium and also numerous TLR2 positive cells in 
the connective tissue, mainly in the vessel’s walls; (c) TLR2 positivity in non-keratinocyte cells; (d) Inconstant 
intensity for TLR4 immune reaction in the epithelium.
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being highly expressed in the basal layer (Figure 2a). In the connective tissue we 
noticed faint positivity in fibroblasts and some endothelial cells (Figure 2b). Cells 
from the perivascular concentrated lymphoplasmacytic infiltrate were intensely 
positive for TLR2. Regarding TLR4 expression, we noticed more intense positive cells 
in the epithelial spinous layer than in the superficial and basal ones. In the connec-
tive tissue, TLR4-positive fibroblasts were increased in number and proinflamma-
tory cells showed discrete positivity (Figure 2c).
For TLR7 and TLR8 expression a comparable distribution between healthy and 
diseased oral tissues was noticed [14].
The antimicrobial effects induced by the activation of TLR2-TLR5 and TLR9 in 
the oral mucosa is also provided by the secretion of antimicrobial substances, more 
important being the α-, β-, and θ-defensins. [14] Defensins represent a class of cat-
ionic antimicrobial peptides secreted by the epithelial cells and neutrophils to play 
pivotal roles in innate and adaptive immunity, as well as roles in non-immunological 
processes. They have evolved to be highly efficient in their antimicrobial responses 
Figure 2. 
TLR2 and TLR4 expression in periodontitis (a) Intense TLR2 positive reaction in the epithelial basal layer; 
(b) TLR2 positive cells spread in the lamina propria and proinflammatory cells concentrated in the proximity 
of vessels; (c) Different intensity of TLR 4 immune reaction through the keratinocyte layer. Fibroblasts show 
intense positivity in the superficial lamina propria. Vessels were was also TLR4 positive.
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to a vast array of pathogens. [51] mRNAs for β-defensins and their protein products 
were identified in the human oral epithelium [52].
Reported data sustains that TLR-induced expression of β-defensins is followed 
by two cellular events: (i) in a positive feedback mechanism, β-defensins themselves 
stimulate TLR signalling, acting as an epithelial immune inducer and (ii) they 
contribute to the recruitment/activation of several professional APCs, i.e. DCs and 
monocytes [52, 53].
5.2 TLR signalling beyond the basal membrane of the oral epithelium
Because the innate immune response is limited, slow and nonspecific for the 
antimicrobial defence, it is necessary to activate the specific immune response rep-
resented by B and T lymphocytes that invade the oral tissues a few days after their 
activation under DCs stimulation. In the oral epithelium, once activated by various 
stimuli, including TLR ligands, DCs (also called Langerhans cells by the analogy 
with those in the epidermis) mature, acquire high phagocytic capacity, express the 
chemokine receptor 7 (CCR7) and become mobiles. Through the lamina propria, 
they migrate to the neighbouring lymph node where they activate CD4 + T cells 
(T helper, Th) [54] being the most potent APCs activating naïve T cells and conse-
quently the main messengers between innate and adaptive immune system. Under 
DCs instructions, CD4 + Th differentiate into various subtypes: Th1, Th2, Th17, T 
regulatory cells (Treg). [54] The action of DCs on T lymphocytes is a complex pro-
cess triggered by a various constellation of cytokines dependent on tissue of origin 
and DCs maturation state. [55] There is little information regarding the subtypes of 
DCs identified in the lamina propria of oral mucosa in humans. DCs have the ability 
to decide whether or not to respond and what kind of immune response to develop 
against a particular pathogen or a group of microorganisms. They are activated not 
only by germs but also by non-immune cells - fibroblasts and keratinocytes, that 
produce proinflammatory cytokines as a result of exposure to various pathogens. 
These substances are able to induce different responses in DCs which in turn are 
provided with the ability to modulate downstream the adaptive immune response.
The number of DCs in gingival mucosa is related to the topographic area and to 
the degree of inflammation. In normal human mucosa their number in the sulcular 
epithelium seems to increase with the accumulation of dental plaque. [50, 56, 57] 
In a model of human gingivitis, some authors showed that the number of DCs 
decreased by day 21st of inflammation. [58] This variation of incidence is in accor-
dance with the observation that DCs could have a stimulating inflammatory effect in 
gingival inflammation by the induction of Th1 or Th17 response through IL-12 and 
IFN ɣ [59] and also a protective effect, cushioning the immune response by stimulat-
ing Treg through IL-10 and TGF- βsecretion [20, 60].
A lower number of LCs or a reduced level of CD1a produced by LCs were found 
in the epithelium during chronic periodontitis compared to gingivitis [59, 61, 62] 
suggesting that LCs leave the oral epithelium as the inflammation progresses. Other 
authors did not notice any difference between healthy and inflamed gingiva in 
periodontitis, or even reported an increased number of DCs. [63, 64] It is difficult 
to monitor the chronological overlap between the disappearance of LCs and the 
degree of inflammation and one can suspect that the development of inflamma-
tion is due to the low number of DCs. In fact, a link between the high incidence 
of periodontitis in elderly and the decreased number of DCs in these subjects was 
highlighted [65].
Chemokines and cytokines produced by DCs in response to their activation 
through the interaction with pathogens, such as P. gingivalis, can attract neutrophils 
and monocytes to the site of inflammation [20].
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Neutrophils and monocytes are the main blood innate immune cells and they 
pass through the capillary wall into the lamina propria of the oral mucosa. IL-8 
secreted by the epithelial cells stimulates through TLR4 the adhesion of endothelial 
cells lining the vessels to monocytes by an increased expression of adhesion mol-
ecules E-selectin, Intercellular Adhesion Molecule-1 (ICAM-1) and Vascular Cell 
Adhesion Molecule-1 (VCAM-1). [66] Once in the tissue, the monocytes mature as 
macrophages or activated macrophages. Depending on the activating substances, 
the macrophages are phenotypically polarised: M1 macrophages are the classic 
macrophagic cell, activated by IFN-ɣ and LPS, while the M2 macrophage phenotype 
is involved in the resolution of inflammation and fibrosis [29].
Both neutrophils and macrophages – phagocytic cells from a myeloid lineage -  
are considered to represent the first line of defence against microbial pathogens. 
Neutrophils express TLR 1, 2, 4-10 and macrophages TLR 1, 2, 4-8 (see Table 1). 
When stimulated via TLR, neutrophils display an increased chemotaxis and syn-
thesis of defensins, proinflammatory cytokines (IL-1, IL-6, TNF-α). [67] All these 
substances are involved in tissue destruction and stimulation of bone resorption. 
Noteworthy, neutrophils migration into JE was dependent of commensal colonisa-
tion and MYD 88 activation pathway. [68, 69] Chang et al. demonstrated that TLR2 
and TLR4 are not required for promoting neutrophil trafficking into JE but may 
substantially contribute to shape the composition of microbiota which may modulate 
neutrophil homeostasis. Direct recognition of bacteria by TLR2 and TLR4 is not 
necessary for neutrophil migration into the gingival sulcus [70].
When exposed to PAMPS, monocytes can differentiate into osteoclasts upon 
direct stimulation of LPS by the help of RANKL [71, 72] and they also produce 
proinflammatory cytokines. In periodontitis, mature osteoclasts derived from 
DCs and monocytes are molecularly identical despite the fact that fewer genes 
must be activated when osteoclasts are formed from DCs than from monocyte 
precursors [73].
Two possibilities of evolution can be described for gingival inflammation: (i) the 
return to tissue homeostasis after an acute inflammation, as a protective response 
to bacterial biofilm, which is an active sequence of events and (ii) the persistence 
of inflammation leading to activation of gingival fibroblasts and myofibroblasts, in 
case of failure of resolution pathways, with destruction of ECM and bone, followed 
by scar formation and fibrosis, preventing the return of tissue homeostasis. [74] 
Various antibodies could be used to identify the fibroblasts phenotype: vimentin, 
α-SMA and S100-A4 (FSP1). There is a marked phenotypic heterogeneity of 
fibroblasts in gingival mucosa, as myofibroblasts are least represented and the cells 
positive for FSP1 are most commonly present. [75] Fibroblasts are intimately linked 
with the immune innate system. Uehara and Takada indicated that almost all TLRs 
from gingival fibroblasts are functionally involved in periodontal inflammatory 
reactions acting mainly by the MYD88 dependent pathway. [5] Once stimulated by 
PAMPs, fibroblasts produce proinflammatory cytokines leading directly to peri-
odontal tissue destruction and bone resorption. Fibroblasts involvement in gingival 
inflammation has been intensively studied in connection to P. gingivalis infection. 
LPS from P. gingivalis activates TLRs from gingival fibroblasts and the synthesis of 
MMP1 and MMP3 to degrade ECM. MMPs in turn induce the expression of IL-1β, 
IL-6, IL-8 and MCP1 [6] which upregulate the inflammatory response in tissue-
dependent manner. When comparing human periodontal ligament fibroblasts 
with human gingival fibroblasts isolated from the same donor to examine IL-8 
responses of the cells to some germs and the possible involvement of the CD14/TLR 
system, the authors found that gingival fibroblasts strongly expressed CD14 mRNA 
and CD14 protein while periodontal ligament fibroblasts showed lower levels of 
expression in both respects.[76] Both types of fibroblasts expressed mRNA of 
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TLR2, TLR4, MD2 and MyD88, with TLR2 expression more intense in cells from the 
periodontal ligament. [76] Moreover, gingival fibroblasts exhibited a stronger IL-8 
response than those from the periodontal ligament to LPS. The ability of periodon-
tal fibroblasts to develop an adequate secondary immune response to P. gingivalis 
LPS could be compromised with persistence of inflammation.
6.  Nucleotide-binding oligomerisation domain (NOD)-like receptors 
signalling
The NOD-like (NLR) family of innate intracellular receptors detects several 
PAMPs and endogenous molecules. In humans, this family contains ~20 members 
classified into five different subfamilies according to their structure: (i) NLRA 
which has an acidic transactivation domain, (ii) NLRB - with a baculovirus inhibi-
tor of apoptosis protein repeat, (iii) NLRC – contains a CARD domain and includes 
NOD1 and NOD2, (iv) NLRP – which as a pyrin domain and responds to multiple 
stimuli forming a multiprotein complex termed NALP – inflammasome, and the 
last (v) NLRX, containing an uncharacterized domain. [31, 77, 78] A number of 
putative ligands of NLRs have been reported, but the field of NLRs ligand identifi-
cation is still open. It is unclear whether NLRs, as well as TLRs, are able to interact 
directly through the LRR domain with their ligands. [79] NODs are cytosolic PRRs 
that bind to peptidoglycan from bacterial cell wall. NOD1 and NOD2 are present 
more or less in the same immune cells as TLR: NOD1 on human mononuclear cells, 
macrophages, epithelial cells, including those from oral epithelium, and dendritic 
cells, while NOD2 is present mostly on phagocytic cells: macrophages, DCs, neu-
trophils [80, 81] and Paneth cells of the small intestine. [82–84] NOD1 is involved 
in recognising cell wall compounds from Gram-negative bacteria, while NOD2 
can sense both Gram-positive and Gram-negative bacterial cell wall components. 
[82, 85] NOD1 plays an essential role in innate immune response, its downstream 
signalling inducing the production of proinflammatory cytokines (IL-6, IL-8, 
TNF-α, hBD-2) and chemokines, as well as compounds with immunoregulatory 
and antimicrobial properties (IFN-γ, hBD-1).
The inflammasome comprises proteins that are assembled by intracytoplasmic 
PRRs. A multitude of inflammasomes exist and these can be activated through 
various mechanisms in order to secrete proinflammatory cytokines. [86] Once 
activated by PAMPs or DAMPs, the NLRPs undergo conformational changes that 
trigger the activation of caspase-1. Afterwards, the maturation of proinflamma-
tory cytokines, such as IL-1β and IL-18, to their active forms follows and finally 
results in inflammation and pyroptosis, a cellular event confirmed in periodontal 
inflammation. [87, 88] Pyroptosis is a proinflammatory programmed cell death 
pathway uniquely dependent on caspase-1. [89] The mechanism and outcome 
of pyroptosis are different from those of apoptosis which actively inhibits 
inflammation.
Fourteen members of the NLRP subfamily are described. [90] Among these, 
expression NLRP2 inflammasome was reported to be decreased in gingival epithelia 
infected by P. gingivalis. [91] NLRP1 and NLRP3 are proposed to be involved in 
inflammasome function in addition to the cytoplasmic receptor absent in mela-
noma 2 (AIM2). [92] AIM2 is the first non-NLR family member that was identified 
to mediate inflammasome assembly and activate the caspase-1 pathway [93] having 
mainly cytosolic dsDNA from viruses, bacteria or the host as ligands. NLRP1, 
NLRP3 and AIM2 may exhibit inflammasome activity in diseases such as type 2 
diabetes, essential hypertension or rheumatoid arthritis [88].
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It is confirmed that the expression level of the inflammasome changes as the 
inflammation destroys the gingival tissues. [91, 94] In an immunohistochemical 
study, Xue et al. described a dissimilar expression pattern of NLRP1, NLRP3 and 
AIM2 in chronic and aggressive periodontitis, demonstrating their involvement 
in the pathogenesis of periodontal diseases to different degrees. [88] NLRP3 was 
significantly higher in chronic periodontitis and more expressed in the gingival 
epithelium than in lamina propria both in periodontitis and gingivitis. The intensity 
was gradually weaker from the top to the basal membrane in chronic periodonti-
tis and opposite in aggressive periodontitis, which strengthens the idea that the 
bacteria outside the gingiva are more important in the pathogenesis of gingivitis 
when in aggressive periodontitis the host factor may be more importantly involved. 
[88] NLRP1 seems not to be an important biomarker for distinguishing gingivitis, 
aggressive and chronic periodontitis, because they observed that NLRP1 was barely 
expressed in gingival tissues in both conditions.
7.  Therapeutic perspectives of TLR targeting in periodontal 
inflammation
Usual practical approaches to reduce bacterial levels to proportions manageable 
by the host innate immune system and limit the aggression of oral pathogens on 
periodontal tissues (scaling, root planning and meticulous oral hygiene techniques) 
[95] are often inefficient and for this reason adjunctive therapeutic strategies have 
been proposed in order to modulate host response.
Since their discovery, TLRs have emerged as pivotal mediators of innate 
host immune and inflammatory response. Due to their role in the recognition 
of PAMPS and DAMPS of various origins and the triggering of a proinflamma-
tory response, TLR-signalling is regarded as a novel therapeutic target. That is 
why research was conducted to develop drugs that exploit TLRs signalling in 
immune therapy, drugs which are already tried to treat diseases, such as asthma 
and chronic obstructive pulmonary disease [96], AIDS [97], hepatitis B [98, 99], 
cancer [100, 101].
To date, several directions for targeting TLR-signalling pathways are discussed:
• Negative regulation for prevention of aberrant activation of TLRs;
• Use of synthetic substitutes;
• TLR as vaccine adjuvants;
• TLR agonists;
• TLR antagonists. [102]
Despite the potential of TLRs to activate the synthesis of protective molecules 
against infection, they can also induce serious immunopathological reactions in 
case of overstimulation or insufficient control due to the limited action of some 
negative regulators. An increased number of negative regulators able to dampen 
the degree and duration of TLR-mediated inflammatory host response were 
proposed.
Negative regulation of TLR signalling can be exerted extracellularly (inhibition 
of receptor function) or intracellularly (inhibition of downstream signalling).
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Negative regulation occurs through different mechanisms:
• Soluble decoy TLRs, for example isoforms of TLR4, induced by various stimuli 
are able to block TLRs signalling and production of corresponding cytokines 
and chemokines; [103]
• Degradation of signal proteins; [104]
• Transcriptional regulation. Several miRNAs are reported to be essential 
modulators of immune pathways because they target adaptor molecules and 
their expression varies following TLR activation [104].
Negative regulators fail to control TLRs signalling because requiring a combina-
tion of effects, their loss leads to hyperactivation and pathogens develop strategies 
to evade TLR signalling. [104] TLRs may be novel therapeutic targets in periodon-
titis since manipulation of their signalling pathways contribute to the control of 
infection and inflammation and TLR agonists could be tested as vaccine adjuvants 
in treating periodontal inflammation [105].
Vaccine adjuvants exert their action by increasing antigen delivery to APCs, 
activating them to produce cytokines and by triggering T lymphocytes response. 
[102, 106] TLRs can function as adjuvant receptors for the recognition of certain 
antigens produced by microorganisms, the stimulation and maturation of APCs and 
the alerting of the immune system [24].
TLR agonists, similar but less toxic than PAMPS, are able to cause DCs matura-
tion. [102] They are small molecules that mimic natural TLR ligands and could have 
improved pharmacological effects.
TLRs agonists are already clinically tested as vaccine adjuvants for cancer, 
allergic and infectious diseases [107].
8. Conclusion
Innate immune receptors are critical in maintaining periodontal health as well 
as in the progression of gingival inflammation by acting on the commensal micro-
biome and as a link to the activation of adaptive immunity. Due to the fact that 
TLRs are important in preserving the periodontium state in healthy conditions and 
TLR-inflammation is responsible for the destructive host reactions in periodontal 
diseases, the development of drugs that target TLR signalling and promote benefi-
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